William Blair analyst Matthew Phipps initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Outperform rating.
Twitter, Google-Backed Indian Social Media Startup Cuts 20% Workforce Amid Pressure From Investors To Reduce Costs
Indian social media startup ShareChat said on Monday that it laid off around 20% of its staff. What…